著者
安藤 利奈 山崎 知恵子 岩城 寛尚 辻井 智明 矢部 勇人 西川 典子 永井 将弘 野元 正弘
出版者
一般社団法人 日本臨床薬理学会
雑誌
臨床薬理 (ISSN:03881601)
巻号頁・発行日
vol.48, no.5, pp.167-171, 2017-09-30 (Released:2017-10-28)
参考文献数
11
被引用文献数
2

Parkinson's disease (PD) causes motor impairment, but motor dysfunction can be improved by treatment. However, the package inserts of PD therapeutic drugs state “do not drive a car” as an important precaution in Japan. In addition, the package insert of non-ergot dopamine agonist (DA) states specifically “do not drive a car or operate a machine” as a warning because non-ergot DA causes sudden sleepiness and somnolence. On the other hand, driving is a very important means of transportation for daily living and work. Even though doctors explain at the clinic that the patients should not drive while on medications, many patients are forced to drive in everyday life. In addition, somnolence and sudden sleepiness differ among individuals. Therefore, doctors are confused about instructing patients to refrain from driving. We investigated the relation between non-ergot DA and driving situation in PD patients, which is a serious issue in the clinical setting. All 362 PD patients who visited our offices were interviewed regarding their driving situation, and detailed medications and car accidents were examine in 154 patients who continued driving a car or stopped driving after the onset of disease. In the investigation of medications, 51 patients were taking non-ergot DA, 36 patients (70.6%) of whom continued to drive. In addition, 20 of 154 patients had serious car accidents, but only six of the accidents were associated with somnolence and sudden sleepiness. In the examination of medications at the time of accident, there was no difference between non-ergot DA and other medications. These results suggest that upon receiving instructions from healthcare professionals, PD patients drive while making appropriate judgment about medication-induced somnolence. However, in this study, the number of patients who experienced serious car accidents was small, and the numbers of patients taking ergot DA and non-ergot DA were limited. Further larger scale study is required to confirm the findings. Preparation of guidelines related to instructions on taking PD medications is necessary, which include medication taking during holidays, consideration of the occurrence of sudden sleepiness and somnolence, and judgement of whether to continue driving.
著者
小寺 祐貴 横尾 慶紀 矢部 勇人 小橋 沙也香 田中 康正 山田 玄 高橋 弘毅
出版者
特定非営利活動法人 日本呼吸器内視鏡学会
雑誌
気管支学 (ISSN:02872137)
巻号頁・発行日
vol.38, no.4, pp.301-305, 2016-07-25 (Released:2016-08-06)
参考文献数
15

背景.先天性食道閉鎖症は多くに気管食道瘻を合併する.多くは新生児期に手術療法を行うが,小児期に食道気管瘻が再開通することがある.症例.35歳女性.新生児期にGross C型先天性食道閉鎖症の手術を受けた.しかし,高校生の頃から肺炎を繰り返すようになった.近医で気管支拡張症と診断されていたが,肺炎を反復するために当科に精査入院となった.胸部X線では左下肺野に浸潤影を認め,胸部CTでは左下葉に限局する囊胞状の気管支拡張症と内腔の液面形成を認めた.また周囲には肺炎像も伴っていた.気管支鏡では気管膜様部に瘻孔を認めたため,気管食道瘻の再発を疑い上部消化管の精査を行った.上部消化管内視鏡では上部食道の前壁に瘻孔を認め,食道造影検査では造影剤が食道瘻孔を通じて気管から左下葉気管支へ流入する所見を認めた.以上から気管食道瘻の再開通と診断し,食道瘻孔部直接縫合閉鎖術を行った.気管支拡張症は長期間の感染の反復により形成されたと考えた.結論.先天性食道閉鎖症の手術歴のある患者が呼吸器感染症を繰り返す場合は,気管食道瘻の再開通の可能性がある.